Cargando…
P-147: COVID-19, impact of vaccination in myeloma patients
BACKGROUND: The worldwide COVID-19 pandemic represents an unprecedented crisis that affects the entire medical community, and appears to be a devastating infection in patients with hematological disorders, including myeloma (MM). Vaccination is therefore crucial in this population. Seroconversion af...
Autores principales: | Hoornaert, Ellen, Dachy, François, Hansenne, Amandine, Lagneaux, Eugénie, Gruson, Damien, Bailly, Sarah, Vekemans, Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580186/ http://dx.doi.org/10.1016/S2152-2650(21)02274-6 |
Ejemplares similares
-
COVID-19: impact of vaccination in myeloma patients
por: Hoornaert, E., et al.
Publicado: (2022) -
P147: Assessing the thoroughness of hand hygiene: “To see is to believe”
por: Chen, Y-C, et al.
Publicado: (2013) -
P-149: Immunogenicity of SARS-CoV-2 vaccine in patients with multiple myeloma
por: Malard, Florent, et al.
Publicado: (2021) -
P02.147. Emotions matter: sustained reductions in chronic non-structural pain after a brief, manualized emotional processing program
por: Schubiner, H, et al.
Publicado: (2012) -
P147 Solriamfetol Titration & AdministRaTion (START): Characteristics of patients with obstructive sleep apnoea (OSA) and prescriber rationale for starting treatment with solriamfetol
por: Singh, H, et al.
Publicado: (2021)